Making Collaboration More Common for Rare Cancers
An AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.
Progress Against Cancer
An AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.
Experts discuss shortcomings of current COVID-19 vaccines in people with cancer while highlighting possibilities of T-cell activation.
From the AACR Annual Meeting, “practice changing” immunotherapy effective against lung cancer, and CAR T-cell therapy targets solid tumors.
Excitement and emotion ran high Sunday morning as Margaret Foti, PhD, MD (hc), chief executive officer of the American...
CAR T-cell therapy approved for relapsed large B-cell lymphoma, and screening catches lung cancer earlier, although disparities persist
Chemo brain may provide clues for long-haul COVID-19, and researchers analyze relationship between obesity and cancer.
In 2015, NFL running back Brandon Bolden was having an incredible season with the New England Patriots. That year,...
For more than 20 years, the Scientist↔Survivor Program (SSP) has played a vital role in the American Association for...
Pilot program emphasizes standards to streamline patient care.
Testing for chromosomal abnormalities and gene mutations helps to direct treatment for patients with AML.